PharmaShots Weekly Snapshots (July 19 - 23, 2021)
Published: July 23, 2021 | Tags: AstraZeneca, Bydureon BCise, exenatide extended-release, US, FDA, Approval, Type2 Diabetes
Published: July 23, 2021 | Tags: ImaginAb, Non-Exclusive License Agreement, Boehringer Ingelheim, CD8 ImmunoPET Technology
Published: July 23, 2021 | Tags: Meiji, Dong-A ST, Intas, Commercialize, DMB-3115, Ustekinumab
Published: July 23, 2021 | Tags: Celltrion, Inhalon, Regdanvimab, CT-P59, COVID-19
Published: July 23, 2021 | Tags: NGM, P-II, CATALINA Study, NGM621, Geographic Atrophy, Age-Related Macular Degeneration
Synaffix Signs a License Agreement with ProfoundBio for ADC Technologies
Published: July 23, 2021 | Tags: Synaffix, License Agreement, ProfoundBio, ADC Technologies
Published: July 22, 2021 | Tags: Merck, Eisai, Keytruda, pembrolizumab, Lenvima, Lenvatinib, US, FDA, Approval, Advanced Endometrial Carcinoma
Published: July 22, 2021 | Tags: bluebird bio, Skysona, elivaldogene autotemcel, Lenti-D, EC, Approval, Cerebral Adrenoleukodystrophy
Mabpharm's Biobetter (CMAB008) for Infliximab Receives NMPA's Approval in China
Published: July 22, 2021 | Tags: Sorrento, Mabpharm, Infliximab Biobetter, Marketing Approval, China
IM Reports Results of IMT-002 in P-Ib MAD Trial for the Treatment of Type 1 Diabetes
Published: July 22, 2021 | Tags: IM, IMT-002, P-Ib, MAD Trial, Type 1 Diabetes, T1D
Published: July 22, 2021 | Tags: Bayer, Merck, Verquvo, vericiguat, EC, Approval, Chronic Heart Failure
Lexeo Acquires Stelios to Expands its Gene Therapy Pipeline for Rare Cardiovascular Diseases
Published: July 22, 2021 | Tags: Lexeo, Stelios, Gene Therapy Pipeline, Programs, Rare Cardiovascular Diseases
Published: July 21, 2021 | Tags: Calliditas, STADA, Commercialize, Specialty Therapy, Chronic Autoimmune Kidney Disease IgAN, EU
Published: July 21, 2021 | Tags: Genentech, Venclexta, venetoclax, Azacitidine, Breakthrough Therapy Designation, Myelodysplastic Syndromes
Published: July 21, 2021 | Tags: Scilex, P-III, C.L.E.A.R. Program, Semdexa, SP-102, Sciatica Pain Management
Published: July 21, 2021 | Tags: Albireo, Bylvay, odevixibat, US, FDA, Approval, Progressive Familial Intrahepatic Cholestasis
Relmada In-Licenses Psilocybin Program from Arbormentis
Published: July 21, 2021 | Tags: Relmada, In Licenses, Psilocybin Program, Arbormentis
Published: July 21, 2021 | Tags: Merck, Islatravir, MK-8591, P-IIa, Clinical Trial, HIV, IAS 2021
Published: July 20, 2021 | Tags: Myovant, Ryeqo, relugolix, estradiol, norethindrone acetate, EC, Approval, Uterine Fibroids
Published: July 20, 2021 | Tags: BioNTech, Kite, Cell Therapy, R&D Platform, Manufacturing Facility, Gaithersburg, MD
Published: July 20, 2021 | Tags: Kadmon, Rezurock, belumosudil, US, FDA, Approval, Chronic Graft Versus Host Disease
Samsung Bioepis Initiates P-III Clinical Trial of SB17 Proposed Biosimilar to Stelara (ustekinumab)
Published: July 20, 2021 | Tags: Samsung Bioepis, P-III, Clinical Trial, SB17, Proposed Biosimilar, Stelara, ustekinumab
Published: July 20, 2021 | Tags: Regeneron, REGEN-COV Antibody Cocktail, casirivimab, imdevimab, MHLW, Approval, COVID-19
Published: July 20, 2021 | Tags: AstraZeneca, License Agreement, Aridis, Suvratoxumab, Pneumonia
Published: July 19, 2021 | Tags: Genentech, Hemlibra, emicizumab-kxwh, P-IIIb, STASEY Study, Hemophilia A
Gilead Reports New Data of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV
Published: July 19, 2021 | Tags: Gilead, Lenacapavir, P-II/III, CAPELLA Trial, HIV
Published: July 19, 2021 | Tags: AstraZeneca, Imfinzi, durvalumab, NMPA, Approval, Extensive-Stage Small Cell Lung Cancer
Published: July 19, 2021 | Tags: Sanofi, Fexinidazole, US, FDA, Approval, Sleeping Sickness
Published: July 19, 2021 | Tags: Merck, Vaxneuvance, Pneumococcal 15-valent Conjugate Vaccine, US, FDA, Approval, Invasive Pneumococcal Disease, 15 Serotypes
Published: July 19, 2021 | Tags: GSK, Daprodustat, Five, P-III, Studies, Anaemia, Chronic Kidney Disease
Related Post: PharmaShots Weekly Snapshots (July 12 - 16, 2021)